[A preliminary report of the Chinese Corynebacterium vaccine with pingyangmycin on the treatment of squamous cell carcinoma of the oral and maxillofacial region].
D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D001428:Bacterial Vaccines / Q000627:therapeutic use*; D001761:Bleomycin / Q000627:therapeutic use* / Q000031:analogs & derivatives; D002294:Carcinoma, Squamous Cell / Q000628:therapy*; D003131:Combined Modality Therapy; D003352:Corynebacterium / Q000276:immunology*; D005260:Female; D006801:Humans; D007573:Jaw Neoplasms / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009062:Mouth Neoplasms / Q000628:therapy*
D000903:Antibiotics, Antineoplastic; D001428:Bacterial Vaccines; D001761:Bleomycin; C021771:zhengguangmycin